Literature DB >> 10510384

An extensive region of an MHC class I alpha 2 domain loop influences interaction with the assembly complex.

Y Y Yu1, H R Turnquist, N B Myers, G K Balendiran, T H Hansen, J C Solheim.   

Abstract

Presentation of antigenic peptides to CTLs at the cell surface first requires assembly of MHC class I with peptide and beta 2-microglobulin in the endoplasmic reticulum. This process involves an assembly complex of several proteins, including TAP, tapasin, and calreticulin, all of which associate specifically with the beta 2-microglobulin-assembled, open form of the class I heavy chain. To better comprehend at a molecular level the regulation of class I assembly, we have assessed the influence of multiple individual amino acid substitutions in the MHC class I alpha 2 domain on interaction with TAP, tapasin, and calreticulin. In this report, we present evidence indicating that many residues surrounding position 134 in H-2Ld influence interaction with assembly complex components. Most mutations decreased association, but one (LdK131D) strongly increased it. The Ld mutants, with the exception of LdK131D, exhibited characteristics suggesting suboptimal intracellular peptide loading, similar to the phenotype of Ld expressed in a tapasin-deficient cell line. Notably, K131D was less peptide inducible than wild-type Ld, which is consistent with its unusually strong association with the endoplasmic reticulum assembly complex.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10510384

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  Productive association between MHC class I and tapasin requires the tapasin transmembrane/cytosolic region and the tapasin C-terminal Ig-like domain.

Authors:  Laura C Simone; Corey J Georgesen; Peter D Simone; Xiaojian Wang; Joyce C Solheim
Journal:  Mol Immunol       Date:  2011-12-12       Impact factor: 4.407

2.  Tapasin discriminates peptide-human leukocyte antigen-A*02:01 complexes formed with natural ligands.

Authors:  Gustav Roder; Linda Geironson; Michael Rasmussen; Mikkel Harndahl; Søren Buus; Kajsa Paulsson
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

3.  Model for the interaction of gammaherpesvirus 68 RING-CH finger protein mK3 with major histocompatibility complex class I and the peptide-loading complex.

Authors:  Xiaoli Wang; Lonnie Lybarger; Rose Connors; Michael R Harris; Ted H Hansen
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

4.  Conformational flexibility of the MHC class I alpha1-alpha2 domain in peptide bound and free states: a molecular dynamics simulation study.

Authors:  Martin Zacharias; Sebastian Springer
Journal:  Biophys J       Date:  2004-10       Impact factor: 4.033

5.  Requirements for the selective degradation of endoplasmic reticulum-resident major histocompatibility complex class I proteins by the viral immune evasion molecule mK3.

Authors:  Xiaoli Wang; Rose Connors; Michael R Harris; Ted H Hansen; Lonnie Lybarger
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

Review 6.  Assembly of MHC class I molecules within the endoplasmic reticulum.

Authors:  Yinan Zhang; David B Williams
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 7.  MHC class I antigen presentation: learning from viral evasion strategies.

Authors:  Ted H Hansen; Marlene Bouvier
Journal:  Nat Rev Immunol       Date:  2009-07       Impact factor: 53.106

8.  Adapter-mediated substrate selection for endoplasmic reticulum-associated degradation.

Authors:  Kathleen Corcoran; Xiaoli Wang; Lonnie Lybarger
Journal:  J Biol Chem       Date:  2009-04-14       Impact factor: 5.157

9.  Polymorphism, natural selection, and structural modeling of class Ia MHC in the African clawed frog (Xenopus laevis).

Authors:  D H Bos; B Waldman
Journal:  Immunogenetics       Date:  2006-04-28       Impact factor: 2.846

Review 10.  What is the role of alternate splicing in antigen presentation by major histocompatibility complex class I molecules?

Authors:  Alan Belicha-Villanueva; Jennifer Blickwedehl; Sarah McEvoy; Michelle Golding; Sandra O Gollnick; Naveen Bangia
Journal:  Immunol Res       Date:  2010-03       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.